Lung Cancers Completed Phase 3 Trials for Dacomitinib (DB11963)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01000025PF-00299804 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Standard Therapy for Advanced or Metastatic CancerTreatment